NVO vs PFE: stock comparison and AI forecast
Novo Nordisk A S (NVO) and Pfizer Inc (PFE) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
NVO Novo Nordisk A S
- Price
- $40.00 -5.3% · 6M
- Market Cap
- $177.76B
- P/E Ratio
- 3.0x
- Size
- large-cap
- AI Forecast
- NO CURRENT FORECAST
PFE Pfizer Inc
- Market Cap
- $170.99B
- P/E Ratio
- 38.0x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- NVO and PFE have similar market capitalizations ($177.76B and $170.99B).
- NVO trades at 3.0 times trailing earnings, PFE at 38.0 times.
- NVO turns 34.0% of its revenue into net income, against 6.3% for PFE.
- NVO carries 1.80 times debt per unit of equity, against 1.29 times for PFE.
- PFE yields 5.73% in dividends; NVO pays none.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | NVO | PFE |
|---|---|---|
| Market Cap | $177.76B | $170.99B |
| P/E Ratio | 2.97x | 37.97x |
| P/B Ratio | – | 1.92x |
| Dividend Yield | – | 5.73% |
| EPS | $13.48 | $0.79 |
| Book Value/Share | – | $15.62 |
| Revenue/Share | $34.48 | $11.16 |
| FCF/Share | $9.66 | $2.07 |
Profitability & Margins
| Metric | NVO | PFE |
|---|---|---|
| ROE | 176.6% | 4.5% |
| ROA | 63.1% | 2.0% |
| ROIC | 132.4% | – |
| Gross Margin | 83.4% | 73.4% |
| Operating Margin | 43.0% | – |
| Net Margin | 34.0% | 6.3% |
| EBT Margin | 42.8% | 6.7% |
| Tax Rate | 20.6% | 4.4% |
Financial Health
| Metric | NVO | PFE |
|---|---|---|
| Current Ratio | 0.80x | 1.42x |
| Quick Ratio | 0.57x | 1.10x |
| D/E Ratio | 1.80x | 1.29x |
| Financial Leverage | 2.80x | 2.30x |
| Working Capital | -$6.79B | $13.28B |
Cash Flow
| Metric | NVO | PFE |
|---|---|---|
| Operating Cash Flow | $64.99B | $14.17B |
| Free Cash Flow | $42.93B | $11.79B |
| Capital Spending | -$22.06B | -$2.39B |
| OCF Growth YoY | 115.7% | 8.4% |
| FCF Growth YoY | 0.0% | 13.6% |
| FCF/Sales | 28.0% | 18.5% |
| CapEx/Sales | 14.4% | 3.8% |
Operational Efficiency
| Metric | NVO | PFE |
|---|---|---|
| Asset Turnover | 1.86x | 0.31x |
| Receivables Turnover | – | 4.5x |
| Inventory Turnover | 3.4x | 1.7x |
| Fixed Assets Turnover | – | 3.3x |
| Days Sales Outstanding | – | 81 days |
| Days Inventory | 108 days | 216 days |
| Payables Period | – | 88 days |
| Cash Conversion Cycle | – | 210 days |
Income Statement
| Metric | NVO | PFE |
|---|---|---|
| Total Revenue | $153.22B | $63.62B |
| Operating Income | $65.83B | – |
| Net Income | $52.04B | $4.03B |
| R&D Expense | $23.79B | $11.52B |
| SG&A Expense | – | $13.81B |
| Cost of Goods Sold | $25.45B | $16.94B |
Dividend & Shareholder Information
| Metric | NVO | PFE |
|---|---|---|
| Dividends Per Share | – | $1.72 |
| Payout Ratio | – | 217.7% |
| Shares Outstanding | 4444M | 5700M |
| Net Income Growth | 104.6% | -59.0% |
| EPS Growth | 24.9% | -55.1% |
NVO vs PFE: stock comparison and AI forecast
Which is bigger, NVO or PFE?
NVO and PFE have similar market capitalizations ($177.76B and $170.99B).
Which is cheaper on earnings, NVO or PFE?
NVO trades at 3.0 times trailing earnings, PFE at 38.0 times.
Which one does Intratio's AI model rank higher, NVO or PFE?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.